|
Sexual Health Exchange, 1997 - no. 4
This section focuses on health promotion strategies, needs assessments, materials and methodology development, and evaluation results.
USA
In 1994, the US National Institute of Health reported the results of a clinical study in which the rate of perinatal HIV transmission was reduced by twothirds through the administration of zidovudine (ZDV). Later that year, the Public Health Service published recommendations on the use of ZDV to reduce perinatal transmission. To assess the implications of the clinical findings for health service delivery and utilization, the Women's Initiative (WIN) for HIV Care and Reduction of Perinatal HIV Transmission was developed.
WIN is collaborative effort between the Bureaus of Maternal and Child Health and Health Resources Development (part of the Health Resources and Services Administration). Its goals and objectives are to:
- facilitate early identification of HIV through models of care that enhance outreach, HIV counselling and voluntary testing services for women of childbearing age (especially during pregnancy)
- facilitate access to and utilization of a comprehensive care system that includes ZDV prophylaxis to reduce perinatal transmission
- promote communitybased consumer education
- train providers, based on their assessed needs, in those communities where women (especially pregnant women and women at risk for or infected by HIV) seek care
- evaluate the efficacy of strategies and models for potential replication.
It was in this context that WIN undertook the creation of a multi-site, multi-agency network. First, exploratory research was carried out to identify essential components for expanding HIV counselling and testing so that the "consumers" -pregnant women living with HIV - can be identified at an early stage and be provided with ZDV prophylaxis. To elicit opinions, the process included focus groups with consumers (e.g., a group of 15 HIV-positive women), four key informant meetings (with care providers, consumers, policy-makers, ethicists and government representatives) and telephone surveys (with sites implementing ZDV prophylaxis). These studies showed that significantly more su pport services would be needed to ensure that women who learn of their HIV status during pregnancy would have access to and could stay in comprehensive care.
Based on the data collected, agencies were invited to present proposals on developing models of care that focused on one or more of the following elements:
- outreach to women of childbearing age
- expanded HIV counselling and testing for pregnant women
- long-term care for pregnant women living with HIV
- protocols for offering ZDV prophylaxis
- consumer involvement in individual decision-making and programme development
- care provider education.
(Illustration: brochure cover)
This brochure was prepared by the US Department of Health and Human Services to inform women about their choices regarding zidovudine (AZT) use during pregnancy
A competitive grants procedure was used to ultimately select projects at ten sites across the country. The selected projects include three from governmental agencies, three run by resource centres and others focusing on statewide or local care, notably paediatric and family AIDS programmes. Each project was asked to carry out a site needs assessment; these showed what sites were already doing to expand provider capacity (e.g., training providers), how consumers were involved in programme development and as staff, and what each site felt they needed to carry out WIN goals. Based on the assessments, two trainings were developed; one focused on the basics of HIV counselling, testing and ZDV prophylaxis while the other was a trainthetrainers session for consumers and providers.
The projects were organized into a network in June 1995 for sharing strategies, overcoming barriers, exchanging educational and other materials and to circulate new clinical information and policies. The WIN Steering Committee has 29 voting members, including a project director and consumer from each of the 10 sites as well as representatives of other involved agencies. The Steering Committee communicates through conference calls and meets facetoface every six months.
Several sub-committees work on issues such as enhancing consumer involvement, counselling and testing, development of a multi-site evaluation system, and clinical managment. All minutes from each committee meeting are circulated to all Steering Committee members.
A major success of the Initiative has been the exchange of information, reducing the amount of "re-inventing the wheel" since many sites have already dealt with issues another site is about to face (e.g., mandatory testing which is decided on a state basis in the USA).
Consumer involvement has been another important achievement. At each site, consumers are either paid, volunteer staff or both. They might work as a member of the multi-disciplinary team providing counselling to clients or as staff in the waiting rooms to help new clients negotiate the system, stay in care and cope with their disease. The consumers also do outreach into the community and public speaking. Here, too, the network has proved useful, enabling projects to share information on how they deal with problems specific to consumer staff (e.g., turnover, illness, overburdening, confidentiality and salary).
Karen Hench, Maternal & Child Health Bureau, US Department of Health and Human Services, 5600 Fishers Lane, Room 18A-27, Rockville, MD 20867, USA; Tel. 1-301-443-7247; Fax: 1-301-443-1728; e-mail: KHench@hrsa.dhhs.gov |